We are live on ! Find out more
O

OrbiMed Portfolio holdings

AUM $4.59B
1-Year Est. Return 125.28%
This Fund
S&P 500
This Quarter Est. Return
-4.57%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$9.86B
AUM Growth
-$803M
Cap. Flow
+$275M
Cap. Flow %
2.79%
Top 10 Hldgs %
30.57%
Holding
177
New
20
Increased
25
Reduced
25
Closed
19

Top Buys

1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$123M
2
NPCE icon
Neuropace
NPCE
+$93.1M
3
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$77.8M
4
JANX icon
Janux Therapeutics
JANX
+$77.2M
5
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$74.2M

Top Sells

1
HAE icon
Haemonetics
HAE
+$94.6M
2
ABCL icon
AbCellera Biologics
ABCL
+$54.5M
3
ADVM
Adverum Biotechnologies
ADVM
+$54.2M
4
MOH icon
Molina Healthcare
MOH
+$38M
5
PAND
Pandion Therapeutics Inc. Common Stock
PAND
+$31.7M

Sector Composition

1 Healthcare 95.36%
2 Technology 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KZR
151
DELISTED
Kezar Life Sciences
KZR
$3.03M 0.03%
+55,719
New +$3.16M
LBPH
152
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$1.03M 0.01%
113,500
-186,500
-62% -$1.86M
PPBT
153
Purple Biotech
PPBT
$1.29M
$86K ﹤0.01%
89
-68
-43% -$62.5K
ADVM
154
DELISTED
Adverum Biotechnologies
ADVM
– –
-550,114
Closed -$54.2M
ALHC icon
155
Alignment Healthcare
ALHC
$4.37B
– –
-800,000
Closed -$17.5M
AXSM icon
156
Axsome Therapeutics
AXSM
$12.1B
– –
0
– –
CMPS
157
Compass Pathways
CMPS
$1.75B
– –
-127,816
Closed -$4.71M
CVAC
158
DELISTED
CureVac
CVAC
– –
0
– –
CVM icon
159
CEL-SCI Corp
CVM
$19.1M
– –
0
– –
FBRX icon
160
Forte Biosciences
FBRX
$889M
– –
-6,387
Closed -$5.47M
HAE icon
161
Haemonetics
HAE
$3.48B
– –
-852,000
Closed -$94.6M
HCAT icon
162
Health Catalyst
HCAT
$175M
– –
-179,598
Closed -$8.4M
INNV icon
163
InnovAge Holding
INNV
$1.6B
– –
-200,000
Closed -$5.16M
LRMR icon
164
Larimar Therapeutics
LRMR
$377M
– –
-617,245
Closed -$9.02M
MAPSW
165
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
– –
-150,200
Closed -$931K
MOH icon
166
Molina Healthcare
MOH
$12.1B
– –
-162,400
Closed -$38M
NTLA icon
167
Intellia Therapeutics
NTLA
$1.81B
– –
-72,500
Closed -$5.82M
NUVB icon
168
Nuvation Bio
NUVB
$2.02B
– –
-800,000
Closed -$8.36M
RNAC icon
169
Cartesian Therapeutics
RNAC
$250M
– –
-11,306
Closed -$1.53M
SANA icon
170
Sana Biotechnology
SANA
$968M
– –
-60,000
Closed -$2.01M
TVTX icon
171
Travere Therapeutics
TVTX
$5.28B
– –
-528,100
Closed -$13.2M
OLK
172
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
– –
-300,000
Closed -$10.8M
TCRR
173
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-249,279
Closed -$5.5M
SGFY
174
DELISTED
Signify Health, Inc.
SGFY
– –
-225,000
Closed -$6.58M
PAND
175
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
– –
-528,229
Closed -$31.7M
3 4 5 6
7

Similar funds

CGI
Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
ECM
Evergreen Capital Management Bellevue, Washington $4.61B AUM 25.58% 1-Year Est. Return